Does the presence of obesity and/or metabolic syndrome affect the course of acute pancreatitis?: A prospective study

Pancreas

Volumn 43, Issue 4, 2014, Pages 565-570

  Sawalhi, Samer ^a   Al Maramhy, Hamdi ^a   Abdelrahman, Abdelrahman I ^b   Allah, Salah Eldin Geib ^a   Al Jubori, Salman ^c  

^a TAIBAH UNIVERSITY   (Saudi Arabia)

^b KING FAHAD SPECIALIST HOSPITAL   (Saudi Arabia)

^c Al Ansar Hospital   (Saudi Arabia)

Author keywords

Acute pancreatitis; Body mass index; Central obesity; Metabolic syndrome; Waist circumference

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; BIOLOGICAL MARKER;

ACUTE PANCREATITIS; ADOLESCENT; ADULT; AGED; APACHE; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; DISEASE COURSE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; TRIACYLGLYCEROL BLOOD LEVEL; VERY ELDERLY; WAIST CIRCUMFERENCE; ACUTE DISEASE; BLOOD; EPIDEMIOLOGY; MIDDLE AGED; PANCREATITIS; PREDICTIVE VALUE; PREVALENCE; PROGNOSIS; RISK FACTOR; SAUDI ARABIA; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; APACHE; BIOLOGICAL MARKERS; BODY MASS INDEX; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; PANCREATITIS; PREDICTIVE VALUE OF TESTS; PREVALENCE; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; SAUDI ARABIA; SEVERITY OF ILLNESS INDEX; WAIST CIRCUMFERENCE; YOUNG ADULT;

EID: 84898421650     PISSN: 08853177     EISSN: 15364828     Source Type: Journal    
DOI: 10.1097/MPA.0000000000000028     Document Type: Article

References (46)

1. Abu-Zidan FM, Bonham MJ,Windsor JA. Severity of acute pancreatitis: a multivariate analysis of oxidative stress markers and modified Glasgow criteria. Br J Surg. 2000;87:1019-1023.
2. Andersson R, Andersson B, Haraldsen P, et al. Incidence, management and recurrence rate of acute pancreatitis. Scand J Gastroenterol. 2004;39:891-894.
3. Mitchell RM, Byrne MF, Baillie J. Pancreatitis. Lancet. 2003;361: 1447-1455.
4. Lindkvist B, Appelros S, Manjer J, et al. A prospective cohort study of smoking in acute pancreatitis. Pancreatology. 2008;8:63-70.
5. Morton C, Klatsky AL, Udaltsova N. Smoking, coffee, and pancreatitis. Am J Gastroenterol. 2004;99:731-738.
6. Ballinger AB, Barnes E, Alstead EM, et al. Is intervention necessary after a first episode of acute idiopathic pancreatitis? Gut. 1996;38:293-295.
7. Papachristou GI, Papachristou DJ, Avula H, et al. Obesity increases the severity of acute pancreatitis: performance of APACHE-O score and correlation with the inflammatory response. Pancreatology. 2006;6:279-285.
8. Johnson CD, Toh SK, Campbell MJ. Combination of APACHE-II score and an obesity score (APACHE-O) for the prediction of severe acute pancreatitis. Pancreatology. 2004;4:1-6.
9. Martínez J, Sánchez-Payá J, Palazón JM, et al. Obesity: a prognostic factor of severity in acute pancreatitis. Pancreas. 1999;19:15-20.
10. Menger MD, Plusczyk T, Vollmar B. Microcirculatory derangements in acute pancreatitis. J Hepatobiliary Pancreat Surg. 2001;8:187-194.
11. Lamas O, Marti A, Martínez JA. Obesity and immunocompetence. Eur J Clin Nutr. 2002;56(suppl 3):S42-S45.
12. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes. 1988;37:1595-1607.
13. Hwang IC, Kim KK, Jee SH, et al. A comparison of predictability of cardiovascular events between each metabolic component in patients with metabolic syndrome based on the revised National Cholesterol Education Program criteria. Yonsei Med J. 2011;52:220-226.
14. Balthazar EJ, Ranson JH, Naidich DP, et al. Acute pancreatitis: prognostic value of CT. Radiology. 1985;156:767-772.
15. Bollen TL, van Santvoort HC, Besselink MG, et al. The Atlanta Classification of acute pancreatitis revisited. Br J Surg. 2008;95:6-21.
16. Hazem ZM. Acute biliary pancreatitis: diagnosis and treatment. Saudi J Gastroenterol. 2009;15:147-155.
17. Seidell JC, Flegal KM. Assessing obesity: classification and epidemiology. Br Med Bull. 1997;53:238-252.
18. Abiko A, Makita S, Naganuma Y, et al. Association between metabolic syndrome and carotid atherosclerosis: relevance of combined criteria including the serum adiponectin level for the general population. Intern Med. 2011;50:381-387.
19. Alberti KG, Zimmet P, Shaw J, et al. The metabolic syndromeVa new worldwide definition. Lancet. 2005;366:1059-1062.
20. Steer LM. Etiology and pathogenesis of acute pancreatitis. Ann Ital Chir. 1995;66:159-163.
21. Funnell IC, Bornman PC, Weakley SP, et al. Obesity: an important prognostic factor in acute pancreatitis. Br J Surg. 1993;80:484-486.
22. Wang SS, Lin XZ, Tsai YT, et al. Clinical significance of ultrasonography, computed tomography, and biochemical tests in the rapid diagnosis of gallstone-related pancreatitis: a prospective study. Pancreas. 1988;3:153-158.
23. Ammori BJ, Boreham B, Lewis P, et al. The biochemical detection of biliary etiology of acute pancreatitis on admission: a revisit in the modern era of biliary imaging. Pancreas. 2003;26:e32-e35.
24. Groves T. Pandemic obesity in Europe. BMJ. 2006;333:1081.
25. Lee YH, Pratley RE. The evolving role of inflammation in obesity and the metabolic syndrome. Curr Diab Rep. 2005;5:70-75.
26. De Waele B, Vanmierlo B, Van Nieuwenhove Y, et al. Impact of body overweight and class I, II and III obesity on the outcome of acute biliary pancreatitis. Pancreas. 2006;32:343-345.
27. Wang SQ, Li SJ, Feng QX, et al. Overweight is an additional prognostic factor in acute pancreatitis: a meta-analysis. Pancreatology. 2011;11:92-98.
28. Hong S, Qiwen B, Ying J, et al. Body mass index and the risk and prognosis of acute pancreatitis: a meta-analysis. Eur J Gastroenterol Hepatol. 2011;23:1136-1143.
29. Tilg H, Moschen AR. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol. 2006;6:772-783.
30. Sempere L, Martinez J, de Madaria E, et al. Obesity and fat distribution imply a greater systemic inflammatory response and a worse prognosis in acute pancreatitis. Pancreatology. 2008;8:257-264.
31. Martínez J, Johnson CD, Sánchez-Payá J, et al. Obesity is a definitive risk factor of severity and mortality in acute pancreatitis: an updated meta-analysis. Pancreatology. 2006;6:206-209.
32. Sadr-Azodi O, Orsini N, Andrén-SandbergA Å , et al. Abdominal and total adiposity and the risk of acute pancreatitis: a population-based prospective cohort study. Am J Gastroenterol. 2013;108:133-139.
33. Lankisch PG, Schirren CA. Increased body weight as a prognostic parameter for complications in the course of acute pancreatitis. Pancreas. 1990;5:626-629.
34. Reeder BA, Senthilselvan A, Després JP, et al. The association of cardiovascular disease risk factors with abdominal obesity in Canada. Canadian Heart Health Surveys Research Group. CMAJ. 1997;157(suppl 1):S39-S45.
35. Zhu S, Wang Z, Heshka S, et al. Waist circumference and obesity-associated risk factors among whites in the third National Health and Nutrition Examination Survey: clinical action thresholds. Am J Clin Nutr. 2002;76:743-749.
36. Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee. World Health Organ Tech Rep Ser. 1995;854:1-452.
37. Yashima Y, Isayama H, Tsujino T, et al. A large volume of visceral adipose tissue leads to severe acute pancreatitis. J Gastroenterol. 2011;46:1213-1218.
38. Mery CM, Rubio V, Duarte-Rojo A, et al. Android fat distribution as predictor of severity in acute pancreatitis. Pancreatology. 2002;2:543-549.
39. Banks PA. A new classification system for acute pancreatitis. Am J Gastroenterol. 1994;89:151-152.
40. Schmidt MI, Watson RL, Duncan BB, et al. Clustering of dyslipidemia, hyperuricemia, diabetes, and hypertension and its association with fasting insulin and central and overall obesity in a general population. Atherosclerosis Risk in Communities Study Investigators. Metabolism. 1996;45:699-706.
41. Suazo-Baráhona J, Carmona-Sánchez R, Robles-Díaz G, et al. Obesity: a risk factor for severe acute biliary and alcoholic pancreatitis. Am J Gastroenterol. 1998;93:1324-1328.
42. Tsai CJ. Is obesity a significant prognostic factor in acute pancreatitis? Dig Dis Sci. 1998;43:2251-2254.
43. Bokova TA, Lebedeva AV. Characteristics of morphofunctional state of the pancreas in children with metabolic syndrome. Eksp Klin Gastroenterol. 2012;1:19-22.
44. Wu Q, Chen G, Wu WM, et al. Metabolic syndrome components and risk factors for pancreatic adenocarcinoma: a case-control study in China. Digestion. 2012;86:294-301.
45. Alexander CM, Landsman PB, Teutsch SM, et al. Third National Health and Nutrition Examination Survey (NHANES III); National Cholesterol Education Program (NCEP). NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes. 2003;52:1210-1214.
46. Sharma A, Muddana V, Lamb J, et al. Low serum adiponectin levels are associated with systemic organ failure in acute pancreatitis. Pancreas. 2009;38:907-912.